Benitec Biopharma Inc. (BNTC)


Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Benitec Biopharma Inc. chart...

About the Company

We do not have any company description for Benitec Biopharma Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

22

Exchange

Nasdaq

$0M

Total Revenue

22

Employees

$17M

Market Capitalization

-0.52

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BNTC News

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

5d ago, source:

First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which ...

Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?

on MSN ago, source:

Benitec Biopharma Inc (NASDAQ:BNTC) released interim clinical data from the 90-day timepoint following the administration of ...

Benitec Biopharma Inc. (BNTC)

4d ago, source: Yahoo Finance

-First efficacy signals demonstrated for a gene therapy under development for Oculopharyngeal Muscular Dystrophy (OPMD) which affects ~15,000 patients worldwide- - BB-301 facilitated improvements ...

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

5d ago, source:

In connection with the PIPE financing, the Company has agreed with long-term investor Suvretta Capital, who is leading the PIPE, to consider Kishen Mehta, a portfolio manager at Suvretta Capital, for ...

Why Benitec Biopharma Is Rising In Pre-market?

5d ago, source:

Benitec Biopharma Inc. (BNTC) reported positive interim clinical data from the 90-day timepoint following the administration of ...

Benitec Biopharma Inc

3mon ago, source: CNN

Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firms' proprietary platforms include DNA-directed RNA ...

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

5d ago, source: Stockhouse

HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company&CloseCurlyDoubleQuote ...

Benitec Biopharma Inc.: Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

5d ago, source: Finanznachrichten

April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a clinical-stage, gene ...

Benitec Biopharma Inc BNTC

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Benitec Biopharma Inc BNTC

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...